Filing Details

Accession Number:
0001209191-20-051302
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-21 17:00:11
Reporting Period:
2020-09-21
Accepted Time:
2020-09-21 17:00:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
907654 Arca Biopharma Inc. ABIO In Vitro & In Vivo Diagnostic Substances (2835) 363855489
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184334 E Robert Conway 11080 Circlepoint Road
Suite 140
Westminster CO 80020
Yes No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-21 10,000 $4.77 11,944 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $4.743 to $4.80. Upon request of the SEC staff, ARCA biopharma, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.